Effect of the acceptance and commitment therapy for patients with type2 diabetes on glucose control and self-management: a Randomized Controlled Trial.

Effect of the acceptance and commitment therapy for patients with type2 diabetes on glucose control and self-management: a Randomized Controlled Trial. - Effect of the acceptance and commitment therapy for patients with type2 diabetes : a Randomized Controlled Trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014265

Enrollment

140

Registered

2014-06-18

Start date

2014-06-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes mellitus

Interventions

Intervention: Acceptance and commitment therapy (3 hours) and education (1 hour) Control: Education alone (4 hours)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Japanese out-patients are included if they were between 20 and 69 years-of-age and have been receiving medical care for more 6 months under diagnosis of type 2 diabetes mellitus according to the classifications by the Japan Diabetes Society and World Health Organization.

Exclusion criteria

Exclusion criteria: 1) cannot understand Japanese well. 2) type1 diabetes and the secondary forms of diabetes. 3) affected with severe diabetes complication; diabetic retinopathy with impaired vision, impaired renal function (eGFR <30 and macroproteinuria), painful neuropathy. 4) affected with severe cardiovascular diseases and decline in ability of daily life. 5) affected with severe mental illness. 6) Cognitive dysfunction; Altzheimer type dementia, vascular dementia, and so on.

Design outcomes

Primary

Measure	Time frame
HbA1c, The Summary of Diabetes Self-Care Activities Measure: J-SDSCA	—

Secondary

Measure	Time frame
body weight, body mass index (BMI), blood pressure, blood lipids, Acceptance and Action Diabetes Questionnaire(AADQ), Problem Areas In Diabetes Survey(PAID), Attentional function scale	—

Countries

Japan

Contacts

Public ContactTomoka Mineyama

Tama Hokubu Medical Center Department of Endocrinology and Metabolisum

tmineyama-tky@umin.ac.jp+81-42-396-3811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026